Unknown

Dataset Information

0

Efficient discovery of potent anti-HIV agents targeting the Tyr181Cys variant of HIV reverse transcriptase.


ABSTRACT: Non-nucleoside reverse transcriptase inhibitors (NNRTIs) that interfere with the replication of human immunodeficiency virus (HIV) are being pursued with guidance from molecular modeling including free-energy perturbation (FEP) calculations for protein-inhibitor binding affinities. The previously reported pyrimidinylphenylamine 1 and its chloro analogue 2 are potent anti-HIV agents; they inhibit replication of wild-type HIV-1 in infected human T-cells with EC(50) values of 2 and 10 nM, respectively. However, they show no activity against viral strains containing the Tyr181Cys (Y181C) mutation in HIV-RT. Modeling indicates that the problem is likely associated with extensive interaction between the dimethylallyloxy substituent and Tyr181. As an alternative, a phenoxy group is computed to be oriented in a manner diminishing the contact with Tyr181. However, this replacement leads to a roughly 1000-fold loss of activity for 3 (2.5 μM). The present report details the efficient, computationally driven evolution of 3 to novel NNRTIs with sub-10 nM potency toward both wild-type HIV-1 and Y181C-containing variants. The critical contributors were FEP substituent scans for the phenoxy and pyrimidine rings and recognition of potential benefits of addition of a cyanovinyl group to the phenoxy ring.

SUBMITTER: Jorgensen WL 

PROVIDER: S-EPMC3183387 | biostudies-other | 2011 Oct

REPOSITORIES: biostudies-other

altmetric image

Publications

Efficient discovery of potent anti-HIV agents targeting the Tyr181Cys variant of HIV reverse transcriptase.

Jorgensen William L WL   Bollini Mariela M   Thakur Vinay V VV   Domaoal Robert A RA   Spasov Krasimir A KA   Anderson Karen S KS  

Journal of the American Chemical Society 20110909 39


Non-nucleoside reverse transcriptase inhibitors (NNRTIs) that interfere with the replication of human immunodeficiency virus (HIV) are being pursued with guidance from molecular modeling including free-energy perturbation (FEP) calculations for protein-inhibitor binding affinities. The previously reported pyrimidinylphenylamine 1 and its chloro analogue 2 are potent anti-HIV agents; they inhibit replication of wild-type HIV-1 in infected human T-cells with EC(50) values of 2 and 10 nM, respectiv  ...[more]

Similar Datasets

| S-EPMC4607639 | biostudies-literature
| S-EPMC1635531 | biostudies-literature
| S-EPMC5314176 | biostudies-literature
| S-EPMC10669680 | biostudies-literature
| S-EPMC10095864 | biostudies-literature
| S-EPMC6378675 | biostudies-literature
| S-EPMC4833373 | biostudies-literature
| S-EPMC4096936 | biostudies-literature
| S-EPMC5114837 | biostudies-literature
| S-EPMC4025836 | biostudies-other